Latest Articles

Publication Date
Letter regarding Griffiths et al. "Anti-Müllerian hormone decreased in women with superficial peritoneal endometriosis and associated with an elevated inflammatory profile".

Published: Aug. 4, 2026, midnight
Investigation of the miRNA27a rs895819, miRNA222 rs2858060 and miRNA499a rs3746444 polymorphisms in Endometriosis.

The present study aimed to determine the allelic and genotypic frequencies of the miRNA27a rs895819, miRNA222 rs2858060 and miRNA499 rs3746444 polymorphisms and their possible association with endometriosis. This case-control study …

Published: Aug. 3, 2026, midnight
# Birth Control Pill Sexuality: Understanding Impacts and Evidence-Based Support for Hormonal Balance *TpTPRPTvj* - FC Bayern

# Birth Control Pill Sexuality: Understanding Impacts and Evidence-Based Support for Hormonal Balance *TpTPRPTvj* FC Bayern

Published: Aug. 1, 2026, 9:56 p.m.
Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial - The Clinical Trial Vanguard

Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial The Clinical Trial Vanguard

Published: Aug. 1, 2026, 6:33 a.m.
Reliability and validity of the 30-second chair-stand test for assessing functional capacity in women with endometriosis: a cross-sectional and longitudinal study.

and Hypothesis: Endometriosis often causes pelvic pain, limiting movement and physical function. Performance-based tests are fundamental to measure functional status among these women. This study aimed to evaluate the reliability …

Published: Aug. 1, 2026, midnight
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial - Proactive financial news

Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial Proactive financial news

Published: July 31, 2026, 3:20 p.m.
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial - Yahoo Finance UK

Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial Yahoo Finance UK

Published: July 31, 2026, 3:09 p.m.
Medicus Pharma gets UAE approval for Phase 2a t... - Pluang

Medicus Pharma gets UAE approval for Phase 2a t... Pluang

Published: July 31, 2026, 1:44 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - Yahoo! Finance Canada

Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix Yahoo! Finance Canada

Published: July 31, 2026, 1:24 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - ca.finance.yahoo.com

Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix ca.finance.yahoo.com

Published: July 31, 2026, 1:24 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!